Photodynamic therapy in lung cancer

ONCOLOGY

Volumn 14, Issue 3, 2000, Pages 379-391

  Ost, David ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA IN SITU; HUMAN; LUNG CARCINOMA; LUNG TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PHOTOCHEMOTHERAPY; REVIEW; TREATMENT OUTCOME;

CARCINOMA IN SITU; CARCINOMA, BRONCHOGENIC; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 0034146381     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jesionek A, Tappeiner VH: Zur behand-lung der hautcarcinomit mit fluoresceirenden stoffen. Muench Med Wochneshr 47:2042, 1903.
2. Figge FHJ, Weiland GS, Manganiello LOJ: Cancer detection and therapy: Affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68:640, 1948.
3. Auber H, Banger G: Untersuchungen uber die rolle der porphyrine bei geschwulstkranken menschen und tieren. Z Krebsforsch 53:65, 1942.
4. Lipson RL, Baldes EJ: The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 82:508, 1960.
5. Lipson RL, Baldes EJ: The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst 26:1, 1961.
6. Gray M, Lipson RL, Mack J Vu, et al: use of hematoporphyrin derivative in detection and management of cervical cancer. Am J Obstet Gynecol 9:766, 1967.
7. Gregorie HG Jr, Horger EO, Ward JL, et al: Hematoporphyrin-derivative fluorescence I malignant neoplasms. Ann Surg 167:820-828, 1968.
8. Lipson RL, Baldes EJ: The hematoporphyrin derivative: A new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 42:623, 1961.
9. Kelly JF, Snell ME, Berenbaum MC: Photodynamic destruction of human bladder carcinoma, Br J Cancer 31:237-244, 1975.
10. Lipson RL, Gray MJ, Baldes EJ: Hematoporphyrin derivative for detection and management of cancer. Proceedings of the 9th International Cancer Congress, Tokyo, Japan, p 393, 1966.